View Older Stories
-
Raymond James Downgrades Universal Health Services (UHS) to Market Perform 'As Rest-of-Year Lift Looking Steeper'
-
Universal Health Services (UHS) PT Lowered to $230 at Mizuho
-
Universal Health Services (UHS) PT Lowered to $230 at TD Cowen
-
Universal Health Services (UHS) PT Lowered to $205 at Piper Sandler
-
UBS Reiterates Buy Rating on Universal Health Services (UHS) Following Q1 Print
-
Universal Health Services (UHS) Reiterated at Neutral by Cantor Fitzgerald Post Q1 Results
-
Universal Health (UHS) Tops Q1 EPS by 18c
-
Universal Health Services (UHS) Reiterated at Neutral by Cantor Fitzgerald on HIX Headwind
-
Universal Health Services (UHS) Reiterated at Neutral by Cantor Fitzgerald
-
Universal Health Services (UHS) PT Lowered to $216 at RBC Capital
-
TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'
-
RBC: "We estimate that the pending FL program would provide a ~$270MM EBITDA benefit for HCA'
-
Universal Health Services Investor Alert: Kehoe Law Firm, P.C. Investigating Potential Breach of Fiduciary Duty Claims - UHS
-
TD Cowen Reiterates Buy Rating on Universal Health Services (UHS)
-
Universal Health (UHS) Reports In-Line Q4 EPS; offers guidance
-
UBS Reiterates Buy Rating on Universal Health Services (UHS)
-
Universal Health Services (UHS) PT Lowered to $245 at TD Cowen
-
Universal Health Services (UHS) DPP More Positive than Consensus - Cantor Fitzgerald
-
Universal Health (UHS) Declares $0.20 Quarterly Dividend; 0.3% Yield
-
Raymond James Upgrades Universal Health Services (UHS) to Outperform
-
Universal Health Services (UHS) PT Raised to $231 at RBC Capital
-
Universal Health Services (UHS) PT Raised to $253 at Guggenheim
-
Universal Health Services (UHS) PT Raised to $233 at Morgan Stanley
-
KeyBanc on Universal Health Services (UHS): 'Good Quarter, Slight Improvement in Patient Vols'
-
Mizuho Reiterates Outperform Rating on Universal Health Services (UHS)
-
Universal Health (UHS) Tops Q3 EPS by 85c, Beats on Revenue; Offers FY25 Guidance
-
Goldman Sachs Assumes Universal Health Services (UHS) at Neutral
-
Cantor Fitzgerald reiterates Neutral rating on Universal Health (UHS)
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
UBS Reiterates Buy Rating on Universal Health Services (UHS)
-
Cantor Fitzgerald Reiterates Neutral Rating on Universal Health Services (UHS)
-
Universal Health (UHS), Others Falls Following Conf.
-
BofA Lists EHC and THC as Top Picks in Healthcare, Sees UHS and ARDT as Worst Positioned
-
Cantor Fitzgerald Reiterates Neutral Rating on Universal Health Services (UHS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Universal Health Services (UHS) PT Raised at RBC Capital Following Guidance Raise
-
Cantor Fitzgerald Reiterates Neutral Rating on Universal Health Services (UHS)
-
UBS Reiterates Buy Rating on Universal Health Services (UHS)
-
TD Cowen Reiterates Buy Rating on Universal Health Services (UHS)
-
Universal Health (UHS) Tops Q2 EPS by 42c, Offers Guidance
-
Universal Health (UHS) Declares $0.20 Quarterly Dividend; 0.5% Yield
-
Universal Health (UHS) Declares $0.20 Quarterly Dividend; 0.5% Yield
-
BofA Securities Downgrades Universal Health Services (UHS) to Underperform
-
Cantor Fitzgerald Reiterates Neutral Rating on Universal Health Services (UHS)
-
UBS Reiterates Buy Rating on Universal Health Services (UHS)
-
Tenet Healthcare (THC) Falls to Low, -4%, Universal Health (UHS) -3.5%
-
Morgan Stanley Reiterates Equalweight Rating on Universal Health Services (UHS)
-
CMS Launches Oversight Initiative on Hospitals Performing Experimental Sex Trait Modification Procedures
-
Cantor Fitzgerald Reiterates Neutral Rating on Universal Health Services (UHS)
-
Universal Health (UHS) Declares $0.20 Quarterly Dividend; 0.4% Yield

